Iron overload patients with unknown etiology from national survey in Japan

被引:0
作者
Katsuya Ikuta
Mayumi Hatayama
Lynda Addo
Yasumichi Toki
Katsunori Sasaki
Yasuaki Tatsumi
Ai Hattori
Ayako Kato
Koichi Kato
Hisao Hayashi
Takahiro Suzuki
Masayoshi Kobune
Miyuki Tsutsui
Akihiko Gotoh
Yasuo Aota
Motoo Matsuura
Yuzuru Hamada
Takahiro Tokuda
Norio Komatsu
Yutaka Kohgo
机构
[1] Asahikawa Medical University,Division of Gastroenterology and Hematology/Oncology, Department of Medicine
[2] Asahikawa Medical University,Department of Gastrointestinal Immunology and Regenerative Medicine
[3] Aichi Gakuin University School of Pharmacy,Laboratory of Medicine
[4] Nagoya University,Department of Hospital Pharmacy
[5] Jichi Medical University,Division of Hematology, Department of Medicine
[6] Sapporo Medical University School of Medicine,Department of Medical Oncology and Hematology
[7] Juntendo University School of Medicine,Division of Hematology, Department of Medicine
[8] Kohsei Chuo General Hospital,Department of Internal Medicine
[9] Sakai City Medical Center,Department of Nephrology, Metabology and Immunology
[10] Kitano Hospital,Tazuke Kofukai Foundation, Medical Research Institute
[11] Saiseikai Yokohama City Eastern Hospital,Department of Cardiovascular Medicine
[12] International University of Health and Welfare,Department of Gastroenterology
来源
International Journal of Hematology | 2017年 / 105卷
关键词
Iron overload; Hemochromatosis; Post-transfusional iron overload; Hereditary hemochromatosis;
D O I
暂无
中图分类号
学科分类号
摘要
Transfusion is believed to be the main cause of iron overload in Japan. A nationwide survey on post-transfusional iron overload subsequently led to the establishment of guidelines for iron chelation therapy in this country. To date, however, detailed clinical information on the entire iron overload population in Japan has not been fully investigated. In the present study, we obtained and studied detailed clinical information on the iron overload patient population in Japan. Of 1109 iron overload cases, 93.1% were considered to have occurred post-transfusion. There were, however, 76 cases of iron overload of unknown origin, which suggest that many clinicians in Japan may encounter some difficulty in correctly diagnosing and treating iron overload. Further clinical data were obtained for 32 cases of iron overload of unknown origin; median of serum ferritin was 1860.5 ng/mL. As occurs in post-transfusional iron overload, liver dysfunction was found to be as high as 95.7% when serum ferritin levels exceeded 1000 ng/mL in these patients. Gene mutation analysis of the iron metabolism-related genes in 27 cases of iron overload with unknown etiology revealed mutations in the gene coding hemojuvelin, transferrin receptor 2, and ferroportin; this indicates that although rare, hereditary hemochromatosis does occur in Japan.
引用
收藏
页码:353 / 360
页数:7
相关论文
共 50 条
  • [31] Iron overload and HFE gene mutations in Polish patients with liver cirrhosis
    Sikorska, Katarzyna
    Romanowski, Tomasz
    Stalke, Piotr
    Izycka-Swieszewska, Ewa
    Bielawski, Krzysztof Piotr
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (03) : 270 - 275
  • [32] Investigation of BMP6 mutations in Brazilian patients with iron overload
    Toreli, Ana Carolina Moura
    Toni, Isabella
    de Albuquerque, Dulcineia Martins
    Lanaro, Carolina
    Maues, Jersey Heitor
    Fertrin, Kleber Yotsumoto
    Campos, Paula de Melo
    Costa, Fernando Ferreira
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S197 - S200
  • [33] USE OF LIVER VOLUME DETERMINATION IN THE ASSESSMENT OF IRON OVERLOAD IN PATIENTS WITH HEMOCHROMATOSIS
    PETERS, TJ
    DUANE, P
    RAJA, K
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1991, 3 (02) : 137 - 141
  • [34] The interactions between iron and copper in genetic iron overload syndromes and primary copper toxicoses in Japan
    Tatsumi, Yasuaki
    Kato, Ayako
    Kato, Koichi
    Hayashi, Hisao
    HEPATOLOGY RESEARCH, 2018, 48 (09) : 679 - 691
  • [35] -174 G>C IL-6 polymorphism and primary iron overload in male patients
    Tetzlaff, Walter F.
    Merono, Tomas
    Botta, Eliana E.
    Martin, Maximiliano E.
    Sorroche, Patricia B.
    Boero, Laura E.
    Castro, Marcelo
    Frechtel, Gustavo D.
    Rey, Jorge
    Daruich, Jorge
    Cerrone, Gloria E.
    Brites, Fernando
    ANNALS OF HEMATOLOGY, 2018, 97 (09) : 1683 - 1687
  • [36] The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload
    Jensen, PD
    Heickendorff, L
    Pedersen, B
    BendixHansen, K
    Jensen, FT
    Christensen, T
    Boesen, AM
    Ellegaard, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (02) : 288 - 299
  • [37] Pancreatic Exocrine Function and Cardiac Iron in Patients With Iron Overload and With Thalassemia
    Yamamura, Jin
    Grosse, Regine
    Jarisch, Andrea
    Janka, Gritta E.
    Nielsen, Peter
    Adam, Gerhard
    Fischer, Roland
    PEDIATRIC BLOOD & CANCER, 2011, 57 (04) : 674 - 676
  • [38] Serum Iron Levels and Hepatic Iron Overload in Patients with Nonalcoholic Steatohepatitis
    Ajay Duseja
    Reena Das
    Ashim Das
    R. K. Dhiman
    Y. K. Chawla
    G. Garewal
    Digestive Diseases and Sciences, 2006, 51 : 1730 - 1731
  • [39] The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients
    Funakoshi, Natalie
    Chaze, Iphigenie
    Alary, Anne-Sophie
    Tachon, Gaelle
    Cunat, Severine
    Giansily-Blaizot, Muriel
    Bismuth, Michael
    Larrey, Dominique
    Pageaux, Georges-Philippe
    Schved, Jean-Francois
    Donnadieu-Rigole, Helene
    Blanc, Pierre
    Aguilar-Martinez, Patricia
    LIVER INTERNATIONAL, 2016, 36 (05) : 746 - 754
  • [40] Serum iron levels and hepatic iron overload in patients with nonalcoholic steatohepatitis
    Duseja, Ajay
    Das, Reena
    Das, Ashim
    Dhiman, R. K.
    Chawla, Y. K.
    Garewal, G.
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (10) : 1730 - 1731